ENTRY       D10897            Mixture   Drug
NAME        Teneligliptin and canagliflozin;
            Teneligliptin and canagliflozin;
            Canalia (TN)
COMPONENT   (Teneligliptin hydrobromide hydrate [DR:D09756] | Teneligliptin [DR:D08616]), Canagliflozin [DR:D09592]
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG03035  Combination of DPP-4 inhibitor and SGLT2 inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG03191  FMO1 substrate
             DG02950  FMO3 substrate
             DG02924  UGT substrate
              DG03188  UGT1A9 substrate
              DG03189  UGT2B4 substrate
            Transporter substrate
             DG01665  ABCB1 substrate
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
REMARK      Therapeutic category: 3969
            Product: D10897<JP>
EFFICACY    Antidiabetic
COMMENT     Teneligliptin is a substrate of CYP3A4, FMO1 and FMO3.
            Canagliflozin is a substrate of UGT1A9 and UGT2B4.
            Teneligliptin and Canagliflozin are inhibitor and substrate of P-gp.
METABOLISM  Enzyme: CYP3A4 [HSA:1576], FMO1 [HSA:2326], FMO3 [HSA:2328], UGT1A9 [HSA:54600], UGT2B4 [HSA:7363]
            Transporter: ABCB1 [HSA:5243]
INTERACTION Transporter inhibition: ABCB1 [HSA:5243]
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               396  Antidiabetic agents
                3969  Others
                 D10897  Teneligliptin and canagliflozin
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG03035  Combination of DPP-4 inhibitor and SGLT2 inhibitor
                D10897  Teneligliptin and canagliflozin
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D10897  Teneligliptin and canagliflozin
              DG03191  FMO1 substrate
               D10897  Teneligliptin and canagliflozin
              DG02950  FMO3 substrate
               D10897  Teneligliptin and canagliflozin
              DG02924  UGT substrate
               DG03188  UGT1A9 substrate
                D10897  Teneligliptin and canagliflozin
               DG03189  UGT2B4 substrate
                D10897  Teneligliptin and canagliflozin
             Transporter substrate
              DG01665  ABCB1 substrate
               D10897  Teneligliptin and canagliflozin
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               D10897  Teneligliptin and canagliflozin
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D10897  Teneligliptin and canagliflozin
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10897
             Drug transporters
              D10897
DBLINKS     PubChem: 340650301
///
